ALX Oncology Holdings Inc.ALXONASDAQ
Loading
EBITDA Over TimeContracting
Percentile Rank43
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Latest
$-100.09M
↓ 19% vs avg
Percentile
P43
Within normal range
Streak
2 yr
Consecutive growthContracting
Average
$-84.06M
Historical baseline
PeriodValueYoY Change
TTM$-100.09M+24.3%
2024$-132.25M+16.5%
2023$-158.40M-29.0%
2022$-122.84M-47.3%
2021$-83.42M-91.9%
2020$-43.46M-131.7%
2019$-18.76M-41.5%
2018$-13.26M-